| Leistung |
Fallzahl |
OPS-Schlüssel |
Info |
| Regelbehandlung bei psychischen und psychosomatischen Störungen und Verhaltensstörungen bei Kindern und Jugendlichen |
650
|
9-656 |
|
|
442
|
9-696.40 |
|
|
395
|
9-696.52 |
|
| Psychiatrisch-psychosomatische Intensivbehandlung bei psychischen und psychosomatischen Störungen und Verhaltensstörungen bei Kindern und Jugendlichen |
356
|
9-672 |
|
|
327
|
9-696.0 |
|
|
307
|
9-696.32 |
|
|
294
|
9-696.53 |
|
|
253
|
9-696.41 |
|
|
222
|
9-696.35 |
|
|
191
|
9-696.33 |
|
|
150
|
9-696.36 |
|
|
139
|
9-696.31 |
|
|
138
|
9-696.10 |
|
|
128
|
9-696.54 |
|
|
112
|
9-696.51 |
|
|
104
|
9-696.56 |
|
|
99
|
9-696.57 |
|
|
98
|
9-696.55 |
|
|
91
|
9-696.34 |
|
|
90
|
9-696.50 |
|
|
82
|
9-696.37 |
|
|
79
|
9-696.20 |
|
|
76
|
9-696.42 |
|
|
74
|
9-696.38 |
|
|
73
|
9-696.12 |
|
|
72
|
9-696.39 |
|
|
71
|
9-696.11 |
|
|
66
|
9-696.30 |
|
|
61
|
9-696.13 |
|
|
51
|
9-696.58 |
|
|
49
|
9-696.4g |
|
|
43
|
9-696.15 |
|
|
39
|
9-696.3a |
|
|
38
|
9-696.14 |
|
|
35
|
9-693.12 |
|
|
32
|
9-696.21 |
|
|
32
|
9-696.59 |
|
|
31
|
9-693.11 |
|
|
26
|
9-693.10 |
|
|
26
|
9-696.5b |
|
|
25
|
9-696.5a |
|
| Elektroenzephalographie [EEG]: Routine-EEG (10/20 Elektroden) |
24
|
1-207.0 |
|
|
24
|
9-696.3b |
|
|
22
|
9-696.18 |
|
|
21
|
9-696.16 |
|
|
20
|
9-696.43 |
|
|
14
|
9-696.3d |
|
|
14
|
9-984.7 |
|
|
13
|
9-696.17 |
|
|
13
|
9-696.3c |
|
|
11
|
9-984.8 |
|
|
10
|
9-696.19 |
|
|
10
|
9-696.3g |
|
|
8
|
9-696.1a |
|
|
8
|
9-696.1g |
|
|
8
|
9-696.3e |
|
|
8
|
9-696.5c |
|
| Computergestützte Bilddatenanalyse mit 3D-Auswertung |
7
|
3-990 |
|
|
7
|
9-696.1b |
|
|
7
|
9-696.5g |
|
|
7
|
9-984.6 |
|
|
6
|
9-693.13 |
|
|
6
|
9-693.14 |
|
|
6
|
9-696.1d |
|
| Native Magnetresonanztomographie des Schädels |
5
|
3-800 |
|
|
5
|
9-696.1c |
|
|
5
|
9-696.5n |
|
| Regelbehandlung bei psychischen und psychosomatischen Störungen und Verhaltensstörungen bei Erwachsenen |
4
|
9-607 |
|
|
4
|
9-696.5h |
|
|
4
|
9-696.5j |
|
| Native Magnetresonanztomographie des Muskel-Skelett-Systems |
k.A.
|
3-806 |
|
| Magnetresonanz-Cholangiopankreatikographie [MRCP]: Ohne Sekretin-Unterstützung |
k.A.
|
3-843.0 |
|
| Magnetresonanz-Cholangiopankreatikographie [MRCP]: Mit Sekretin-Unterstützung |
k.A.
|
3-843.1 |
|
| Applikation von Medikamenten, Liste 1: Adalimumab, parenteral: 80 mg bis unter 120 mg 80 mg bis unter 120 mg |
k.A.
|
6-001.d3 |
|
|
k.A.
|
6-008.4 |
|
| Intensivbehandlung bei psychischen und psychosomatischen Störungen und Verhaltensstörungen bei erwachsenen Patienten mit 1 Merkmal |
k.A.
|
9-617 |
|
|
k.A.
|
9-649.0 |
|
|
k.A.
|
9-649.10 |
|
|
k.A.
|
9-649.30 |
|
|
k.A.
|
9-649.31 |
|
|
k.A.
|
9-693.00 |
|
|
k.A.
|
9-693.15 |
|
|
k.A.
|
9-696.1e |
|
|
k.A.
|
9-696.1f |
|
|
k.A.
|
9-696.23 |
|
|
k.A.
|
9-696.3f |
|
|
k.A.
|
9-696.44 |
|
|
k.A.
|
9-696.45 |
|
|
k.A.
|
9-696.46 |
|
|
k.A.
|
9-696.47 |
|
|
k.A.
|
9-696.5d |
|
|
k.A.
|
9-696.5e |
|
|
k.A.
|
9-696.5f |
|
|
k.A.
|
9-696.5k |
|
|
k.A.
|
9-696.5q |
|
|
k.A.
|
9-696.5t |
|
|
k.A.
|
9-696.5v |
|
|
k.A.
|
9-984.9 |
|
|
k.A.
|
9-984.a |
|
|
k.A.
|
9-984.b |
|
